Beta Drugs Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	424.19	364.37	307.19	248.28	117.25
Depreciation & Amortization	113.75	97.82	104.1	72.54	68.74
Other Amortization	11.39	-	-	-	-
Other Operating Activities	2.39	-17.12	19.47	73.18	38.94
Change in Accounts Receivable	-233.38	-165.17	-175.41	-113.05	-19.5
Change in Inventory	-99.6	-191.94	-81.37	-64.39	-36.96
Change in Accounts Payable	119.76	190.33	82.88	114.58	60.05
Change in Other Net Operating Assets	22.96	31.01	-23.04	-34.86	-42.52
Operating Cash Flow	361.44	309.3	233.83	296.28	186
Operating Cash Flow Growth	16.86%	32.28%	-21.08%	59.29%	121.06%
Capital Expenditures	-368.59	-116.16	-182.12	-194.28	-57.56
Investment in Securities	-	7.79	-	-	-4.27
Other Investing Activities	51.1	10.84	6.63	4.52	3.34
Investing Cash Flow	-357.18	-139.72	-190.69	-217.55	-58.48
Short-Term Debt Issued	7.56	-	43.14	12.14	-
Long-Term Debt Issued	1,237	-	-	6.08	8.14
Total Debt Issued	1,245	-	43.14	18.22	8.14
Short-Term Debt Repaid	-	-41.11	-	-	-61.08
Long-Term Debt Repaid	-	-5.59	-43.73	-	-
Total Debt Repaid	-	-46.7	-43.73	-	-61.08
Net Debt Issued (Repaid)	1,245	-46.7	-0.59	18.22	-52.94
Issuance of Common Stock	4.81	-	-	-	-
Other Financing Activities	-69.89	-28.2	-24.15	-27.95	-24.2
Financing Cash Flow	1,180	-74.9	-24.74	-9.74	-77.14
Miscellaneous Cash Flow Adjustments	-	-	-0	-	-
Net Cash Flow	1,184	94.69	18.4	68.99	50.38
Free Cash Flow	-7.14	193.15	51.71	102	128.44
Free Cash Flow Growth	-	273.55%	-49.31%	-20.59%	-
Free Cash Flow Margin	-0.20%	6.53%	2.28%	5.55%	11.06%
Free Cash Flow Per Share	-0.71	20.09	5.12	10.11	12.72
Cash Interest Paid	46.08	9.81	22.8	17.89	22.2
Levered Free Cash Flow	-88.99	134.52	-17.57	0.72	65.3
Unlevered Free Cash Flow	-46.86	151.25	-3.32	11.9	79.18
Change in Working Capital	-190.28	-135.77	-196.94	-97.72	-38.93

Source: S&P Global Market Intelligence. Standard template. Financial Sources.